China Traditional Chinese Medicine Holdings Co. Limited

Equities

570

HK0000056256

Pharmaceuticals

Market Closed - Hong Kong S.E. 04:08:35 2024-04-19 am EDT 5-day change 1st Jan Change
4.32 HKD +0.23% Intraday chart for China Traditional Chinese Medicine Holdings Co. Limited -0.23% +9.92%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
China Traditional Chinese Medicine Posts 94% Profit Growth in 2023 MT
China Traditional Chinese Medicine Holdings Co. Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
China Traditional Chinese Medicine Holdings Co. Limited Announces Re-Designation of CHENG Xueren from Managing Director to Non-Executive Director CI
China Traditional Chinese Medicine Holdings Co. Limited Announces Board Changes CI
China Traditional Chinese Medicine's Stock Bolts on Privatization Offer MT
China stocks extend gains led by coal, AI; HK shares up RE
Hong Kong Stocks Hover Near Two-Month Highs Amid Mixed Corporate Earnings MT
China stocks jump with AI shares leading on Nvidia forecast; HK shares flat RE
Sinopharm offers to take China-TCM private in nearly $3 bln deal RE
Sinopharm Common Wealth Company Limited entered into a scheme of arrangement to acquire 67.54% stake in China Traditional Chinese Medicine Holdings Co. Limited for HKD 15.6 billion. CI
China Traditional Chinese Medicine Holdings Forecasts Up to 95% Surge in 2023 Profit; Shares Rise 4% MT
China Traditional Chinese Medicine Holdings Co. Limited Provides Preliminary Unaudited Consolidated Earnings Guidance for the Year Ended 31 December 2023 CI
China Traditional Chinese Medicine Holdings Co. Limited Reports Earnings Results for the Half Year Ended June 30, 2023 CI
China Traditional Chinese Medicine Holdings Co. Limited Announces Resignation of Kui Kaipin as Non-Executive Director, with Effect from August 29, 2023 CI
China Traditional Chinese Medicine's Profit to Climb Up to 55% in H1; Shares Up 3% MT
China Traditional Chinese Medicine Holdings Co. Limited Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2023 CI
China Traditional Chinese Medicine Raises Issues 800 Million Yuan of 270-Day Bonds MT
China Traditional Chinese Medicine Holdings Co. Limited Approves Final Dividend for the Year Ended 31 December 2022 CI
China Traditional Chinese Medicine Raises 2.2 Billion Yuan from Issuing Two Series of Bonds MT
China Traditional Chinese Medicine Holdings Co. Limited Proposes Final Dividend for the Year Ended 31 December 2022 CI
China Traditional Chinese Medicine Holdings Co. Limited Proposes Final Dividend for the Year Ended 31 December 2022, Payable on 20 June 2023 CI
China Traditional Chinese Medicine Holdings Co. Limited Reports Earnings Results for the Full Year Ended December 31, 2022 CI
China Traditional Chinese Medicine Forecasts Up to 70% Decline in FY22 Profit MT
China Traditional Chinese Medicine Holdings Co. Limited Provides Preliminary Unaudited Consolidated Group Earnings Guidance for the Year Ended 31 December 2022 CI
China Traditional Chinese Medicine Holdings Co. Limited Announces Management Changes CI
Chart China Traditional Chinese Medicine Holdings Co. Limited
More charts
China Traditional Chinese Medicine Holdings Co. Limited is principally engaged in the manufacture and sales of traditional Chinese medicine (TCM). The Company operates through 12 subsidiaries, including Sinopharm Group Dezhong (Foshan) Pharmaceutical Co., Ltd., Sinopharm Group Feng Liao Xing (Foshan) Pharmaceutical Co., Ltd., Sinopharm Group Guangdong Medi-World Pharmaceutical Co., Ltd., Sinopharm Group Luya (Shandong) Pharmaceutical Co., Ltd., Sinopharm Group Feng Liao Xing (Foshan) Medicinal Material & Slices Co., Ltd., Foshan Winteam Pharmaceutical Sales Company Limited, Sinopharm Group Tongjitang (Guizhou) Pharmaceutical Co., Ltd., Sinopharm Group Jingfang (Anhui) Pharmaceutical Co., Ltd., Sinopharm Group Longlife (Guizhou) Pharmaceutical Co., Ltd., Qinghai Pulante Pharmaceutical Co., Ltd., Guizhou Zhongtai Biological Technology Company Limited and its subsidiaries and Jiangyin Tianjiang Pharmaceutical Co., Ltd. and its subsidiaries.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
3.993 CNY
Average target price
4.342 CNY
Spread / Average Target
+8.74%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 570 Stock
  4. News China Traditional Chinese Medicine Holdings Co. Limited
  5. China Traditional Chinese Medicine's Stock Bolts on Privatization Offer